Histone lysine methyltransferase-related neurodevelopmental disorders: current knowledge and saRNA future therapies

Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that c...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cell and developmental biology Vol. 11; p. 1090046
Main Authors Roth, Charlotte, Kilpinen, Helena, Kurian, Manju A, Barral, Serena
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.02.2023
Subjects
brain organoids
Cell and Developmental Biology
epigenetics (chromatin remodeling)
histone lysine methyltransferases (HKMTs)
neurodevelopmental disorders (NDDs)
small-activating RNA (saRNA)
epigenetics (chromatin remodeling)
small-activating RNA (saRNA)
histone lysine methyltransferases (HKMTs)
brain organoids
neurodevelopmental disorders (NDDs)
Online AccessGet full text

Cover

Abstract Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that cause Neurodevelopmental disorders. Chromatin remodelers play a key role in the neuro-epigenetic landscape and regulation of brain development; it is therefore not surprising that mutations, leading to loss of protein function, result in aberrant neurodevelopment. Heterozygous, usually mutations in histone lysine methyltransferases have been described in patients leading to haploinsufficiency, dysregulated protein levels and impaired protein function. Studies in animal models and patient-derived cell lines, have highlighted the role of histone lysine methyltransferases in the regulation of cell self-renewal, cell fate specification and apoptosis. To date, in depth studies of histone lysine methyltransferases in oncology have provided strong evidence of histone lysine methyltransferase dysregulation as a determinant of cancer progression and drug resistance. As a result, histone lysine methyltransferases have become an important therapeutic target for the treatment of different cancer forms. Despite recent advances, we still lack knowledge about the role of histone lysine methyltransferases in neuronal development. This has hampered both the study and development of precision therapies for histone lysine methyltransferases-related Neurodevelopmental disorders. In this review, we will discuss the current knowledge of the role of histone lysine methyltransferases in neuronal development and disease progression. We will also discuss how RNA-based technologies using small-activating RNAs could potentially provide a novel therapeutic approach for the future treatment of histone lysine methyltransferase haploinsufficiency in these Neurodevelopmental disorders, and how they could be first tested in state-of-the-art patient-derived neuronal models.
AbstractList Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that cause Neurodevelopmental disorders. Chromatin remodelers play a key role in the neuro-epigenetic landscape and regulation of brain development; it is therefore not surprising that mutations, leading to loss of protein function, result in aberrant neurodevelopment. Heterozygous, usually de novo mutations in histone lysine methyltransferases have been described in patients leading to haploinsufficiency, dysregulated protein levels and impaired protein function. Studies in animal models and patient-derived cell lines, have highlighted the role of histone lysine methyltransferases in the regulation of cell self-renewal, cell fate specification and apoptosis. To date, in depth studies of histone lysine methyltransferases in oncology have provided strong evidence of histone lysine methyltransferase dysregulation as a determinant of cancer progression and drug resistance. As a result, histone lysine methyltransferases have become an important therapeutic target for the treatment of different cancer forms. Despite recent advances, we still lack knowledge about the role of histone lysine methyltransferases in neuronal development. This has hampered both the study and development of precision therapies for histone lysine methyltransferases-related Neurodevelopmental disorders. In this review, we will discuss the current knowledge of the role of histone lysine methyltransferases in neuronal development and disease progression. We will also discuss how RNA-based technologies using small-activating RNAs could potentially provide a novel therapeutic approach for the future treatment of histone lysine methyltransferase haploinsufficiency in these Neurodevelopmental disorders, and how they could be first tested in state-of-the-art patient-derived neuronal models.Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that cause Neurodevelopmental disorders. Chromatin remodelers play a key role in the neuro-epigenetic landscape and regulation of brain development; it is therefore not surprising that mutations, leading to loss of protein function, result in aberrant neurodevelopment. Heterozygous, usually de novo mutations in histone lysine methyltransferases have been described in patients leading to haploinsufficiency, dysregulated protein levels and impaired protein function. Studies in animal models and patient-derived cell lines, have highlighted the role of histone lysine methyltransferases in the regulation of cell self-renewal, cell fate specification and apoptosis. To date, in depth studies of histone lysine methyltransferases in oncology have provided strong evidence of histone lysine methyltransferase dysregulation as a determinant of cancer progression and drug resistance. As a result, histone lysine methyltransferases have become an important therapeutic target for the treatment of different cancer forms. Despite recent advances, we still lack knowledge about the role of histone lysine methyltransferases in neuronal development. This has hampered both the study and development of precision therapies for histone lysine methyltransferases-related Neurodevelopmental disorders. In this review, we will discuss the current knowledge of the role of histone lysine methyltransferases in neuronal development and disease progression. We will also discuss how RNA-based technologies using small-activating RNAs could potentially provide a novel therapeutic approach for the future treatment of histone lysine methyltransferase haploinsufficiency in these Neurodevelopmental disorders, and how they could be first tested in state-of-the-art patient-derived neuronal models.
Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that cause Neurodevelopmental disorders. Chromatin remodelers play a key role in the neuro-epigenetic landscape and regulation of brain development; it is therefore not surprising that mutations, leading to loss of protein function, result in aberrant neurodevelopment. Heterozygous, usually de novo mutations in histone lysine methyltransferases have been described in patients leading to haploinsufficiency, dysregulated protein levels and impaired protein function. Studies in animal models and patient-derived cell lines, have highlighted the role of histone lysine methyltransferases in the regulation of cell self-renewal, cell fate specification and apoptosis. To date, in depth studies of histone lysine methyltransferases in oncology have provided strong evidence of histone lysine methyltransferase dysregulation as a determinant of cancer progression and drug resistance. As a result, histone lysine methyltransferases have become an important therapeutic target for the treatment of different cancer forms. Despite recent advances, we still lack knowledge about the role of histone lysine methyltransferases in neuronal development. This has hampered both the study and development of precision therapies for histone lysine methyltransferases-related Neurodevelopmental disorders. In this review, we will discuss the current knowledge of the role of histone lysine methyltransferases in neuronal development and disease progression. We will also discuss how RNA-based technologies using small-activating RNAs could potentially provide a novel therapeutic approach for the future treatment of histone lysine methyltransferase haploinsufficiency in these Neurodevelopmental disorders, and how they could be first tested in state-of-the-art patient-derived neuronal models.
Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that cause Neurodevelopmental disorders. Chromatin remodelers play a key role in the neuro-epigenetic landscape and regulation of brain development; it is therefore not surprising that mutations, leading to loss of protein function, result in aberrant neurodevelopment. Heterozygous, usually mutations in histone lysine methyltransferases have been described in patients leading to haploinsufficiency, dysregulated protein levels and impaired protein function. Studies in animal models and patient-derived cell lines, have highlighted the role of histone lysine methyltransferases in the regulation of cell self-renewal, cell fate specification and apoptosis. To date, in depth studies of histone lysine methyltransferases in oncology have provided strong evidence of histone lysine methyltransferase dysregulation as a determinant of cancer progression and drug resistance. As a result, histone lysine methyltransferases have become an important therapeutic target for the treatment of different cancer forms. Despite recent advances, we still lack knowledge about the role of histone lysine methyltransferases in neuronal development. This has hampered both the study and development of precision therapies for histone lysine methyltransferases-related Neurodevelopmental disorders. In this review, we will discuss the current knowledge of the role of histone lysine methyltransferases in neuronal development and disease progression. We will also discuss how RNA-based technologies using small-activating RNAs could potentially provide a novel therapeutic approach for the future treatment of histone lysine methyltransferase haploinsufficiency in these Neurodevelopmental disorders, and how they could be first tested in state-of-the-art patient-derived neuronal models.
Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease severity. Advances in genetic diagnostic tools have facilitated the identification of several monogenic chromatin remodeling diseases that cause Neurodevelopmental disorders. Chromatin remodelers play a key role in the neuro-epigenetic landscape and regulation of brain development; it is therefore not surprising that mutations, leading to loss of protein function, result in aberrant neurodevelopment. Heterozygous, usually de novo mutations in histone lysine methyltransferases have been described in patients leading to haploinsufficiency, dysregulated protein levels and impaired protein function. Studies in animal models and patient-derived cell lines, have highlighted the role of histone lysine methyltransferases in the regulation of cell self-renewal, cell fate specification and apoptosis. To date, in depth studies of histone lysine methyltransferases in oncology have provided strong evidence of histone lysine methyltransferase dysregulation as a determinant of cancer progression and drug resistance. As a result, histone lysine methyltransferases have become an important therapeutic target for the treatment of different cancer forms. Despite recent advances, we still lack knowledge about the role of histone lysine methyltransferases in neuronal development. This has hampered both the study and development of precision therapies for histone lysine methyltransferases-related Neurodevelopmental disorders. In this review, we will discuss the current knowledge of the role of histone lysine methyltransferases in neuronal development and disease progression. We will also discuss how RNA-based technologies using small-activating RNAs could potentially provide a novel therapeutic approach for the future treatment of histone lysine methyltransferase haploinsufficiency in these Neurodevelopmental disorders, and how they could be first tested in state-of-the-art patient-derived neuronal models.
Author Roth, Charlotte
Kurian, Manju A
Barral, Serena
Kilpinen, Helena
AuthorAffiliation 1 Molecular Neurosciences , Developmental Neurosciences Programme , Zayed Centre for Research into Rare Disease in Children , Great Ormond Street Institute of Child Health , University College London , London , United Kingdom
4 Department of Neurology , Great Ormond Street Hospital for Children , London , United Kingdom
2 Helsinki Institute of Life Science , University of Helsinki , Helsinki , Finland
3 Faculty of Biological and Environmental Sciences , University of Helsinki , Helsinki , Finland
AuthorAffiliation_xml – name: 3 Faculty of Biological and Environmental Sciences , University of Helsinki , Helsinki , Finland
– name: 1 Molecular Neurosciences , Developmental Neurosciences Programme , Zayed Centre for Research into Rare Disease in Children , Great Ormond Street Institute of Child Health , University College London , London , United Kingdom
– name: 2 Helsinki Institute of Life Science , University of Helsinki , Helsinki , Finland
– name: 4 Department of Neurology , Great Ormond Street Hospital for Children , London , United Kingdom
Author_xml – sequence: 1
  givenname: Charlotte
  surname: Roth
  fullname: Roth, Charlotte
  organization: Molecular Neurosciences, Developmental Neurosciences Programme, Zayed Centre for Research into Rare Disease in Children, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
– sequence: 2
  givenname: Helena
  surname: Kilpinen
  fullname: Kilpinen, Helena
  organization: Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland
– sequence: 3
  givenname: Manju A
  surname: Kurian
  fullname: Kurian, Manju A
  organization: Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom
– sequence: 4
  givenname: Serena
  surname: Barral
  fullname: Barral, Serena
  organization: Molecular Neurosciences, Developmental Neurosciences Programme, Zayed Centre for Research into Rare Disease in Children, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36923252$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1vEzEQQC1UREvpH-CA9shlg7_WsbmgqiptpQokBBI3y2uPky3OOtjeovz7eptQtaexxjPP43lv0dEYR0DoPcELxqT65C2EsKCYsgXBCmMuXqETSpVoBeO_j56dj9FZzncYY0K7ZSfZG3TMhKKMdvQE5eshl0puwi4PNWygrHehJDNmD8lkaBMEU8A1I0wpOriHELcbGIsJjRtyTA5S_tzYKaWabP6M8V8At4LGjK7J5se388ZPZUrQlHUFbgfI79Brb0KGs0M8Rb--Xv68uG5vv1_dXJzftpYLVVpGlgQTD5JTzhy3RvWOql5I4aQygnLpPCgrbAeSSK-8N4YtlcWScyokY6foZs910dzpbRo2Ju10NIN-TMS00iaVwQbQS8K56j13daHc9UySrlcCM-n63hGglfVlz9pO_QacrX9NJryAvrwZh7VexXtN6uIVFfM0Hw-EFP9OkIveDHmWaEaIU9ZUdnVuRdRcSvelNsWcE_indwjWs339aF_P9vXBfm368HzCp5b_rtkDxGOxRA
CitedBy_id crossref_primary_10_3390_antiox13060678
Cites_doi 10.1038/nature22330
10.1038/nature07829
10.1016/j.ajhg.2011.11.021
10.1093/nar/gkw076
10.1093/nar/gkv143
10.1016/j.celrep.2022.110790
10.1200/JCO.2007.11.2599
10.1038/nsmb1131
10.1136/jmedgenet-2021-107751
10.1038/s41586-022-04556-w
10.1523/JNEUROSCI.3004-14.2015
10.1093/brain/awaa304
10.1038/s41580-022-00518-2
10.1016/S1474-4422(22)00339-8
10.1089/nat.2021.0115
10.1016/j.stem.2016.07.005
10.1038/nature12517
10.1038/srep39311
10.1095/biolreprod.115.131516
10.1016/j.biopsych.2014.11.001
10.3389/fnins.2021.776809
10.1073/pnas.96.26.14967
10.1136/jmg.2008.062950
10.1016/j.celrep.2014.05.026
10.1200/JCO.22.01297
10.1016/s0022-3476(81)80256-9
10.1016/j.celrep.2020.108126
10.1016/S2215-0366(16)30376-5
10.1016/s0955-0674(02)00335-6
10.1073/pnas.0802917105
10.1016/s0006-291x(67)80010-x
10.3390/cells10102527
10.1074/jbc.M101914200
10.31887/DCNS.2020.22.1/macrocq
10.1038/nrg1500
10.1001/jamapsychiatry.2021.3815
10.1007/BF00593411
10.1016/j.ydbio.2005.04.005
10.1016/j.ccr.2014.04.018
10.1126/science.284.5423.2174
10.1016/j.neuron.2019.09.014
10.1074/jbc.M701574200
10.1038/s41388-018-0273-5
10.1073/pnas.0902873106
10.1016/j.str.2020.07.002
10.1038/s41573-020-0075-7
10.1038/nature10351
10.1158/0008-5472.CAN-12-1871
10.1073/pnas.1606857113
10.1038/ng1531
10.1097/WCO.0000000000000710
10.1158/1078-0432.CCR-21-0986
10.1038/nsmb1140
10.1016/j.ymthe.2017.07.018
10.1073/pnas.0503072102
10.1093/nar/gku484
10.1242/dev.169102
10.1016/j.jaci.2019.11.034
10.1038/sj.onc.1204505
10.1371/journal.pone.0014102
10.1007/s00439-016-1668-4
10.1146/annurev.bi.44.070175.002251
10.1021/bi00889a003
10.1002/hep.26669
10.1093/hmg/ddaa175
10.1158/1078-0432.CCR-20-0414
10.1128/MCB.01181-13
10.1038/s41596-018-0066-x
10.1038/s41591-022-01866-4
10.1136/jmedgenet-2019-106756
10.1074/jbc.M504012200
10.1158/1078-0432.CCR-03-0297
10.1038/s41586-021-03828-1
10.1038/nsmb.1444
10.1007/s12026-015-8707-4
10.1038/nature02985
10.1038/ng.3792
10.1186/s13148-019-0802-2
10.2174/138920110791591463
10.1016/0955-2863(90)90070-2
10.1016/j.ajhg.2012.06.008
10.1038/nn.4267
10.1038/nrg3173
10.1016/j.ajhg.2017.11.013
10.1038/nature21062
10.1128/MCB.00993-07
10.3390/pediatric14010019
10.1186/s13148-021-01145-y
10.1073/pnas.0607015103
10.1002/humu.22547
10.1016/j.ccr.2014.03.016
10.1038/s41596-020-00433-w
10.1111/j.1469-7610.2004.00215.x
10.1371/journal.pone.0008848
10.1016/s1097-2765(04)00081-4
10.1038/nbt.3906
10.1038/s41587-020-00763-w
10.1002/ajmg.a.38193
10.1038/47412
10.1074/jbc.M707974200
10.1126/science.1237905
10.1186/s13148-019-0749-3
10.1038/s41388-018-0126-2
10.1016/j.ajhg.2016.10.010
10.1038/nature13772
10.1038/nature01550
10.1126/science.1090674
10.1038/s41467-021-24524-8
10.1074/jbc.M110.203380
10.1038/71750
10.1016/j.omtn.2021.02.007
10.1016/j.bbadis.2018.03.020
10.1086/505693
10.1074/jbc.M112.364125
10.1242/dev.00452
10.1007/s12264-019-00400-w
10.1016/s0021-9258(18)68837-4
10.1002/mgg3.1923
10.1002/epi4.12339
10.1016/j.celrep.2017.08.058
10.1371/journal.pgen.1010278
10.1523/JNEUROSCI.3356-12.2013
10.1038/s41467-020-19572-5
10.1038/s41467-019-13550-2
10.1038/cgt.2012.22
10.1038/s41434-019-0095-2
10.15252/embj.2020106459
10.1128/MCB.24.1.306-319.2004
10.1038/cr.2016.22
10.1186/s13034-022-00462-1
10.1038/311532a0
10.3389/fnmol.2021.772000
10.1016/j.celrep.2017.06.072
10.1038/s41586-018-0566-4
10.1016/j.ymthe.2019.02.018
10.1016/j.stem.2016.12.007
10.1023/a:1025054610557
10.1038/ng.646
10.1016/s0378-1119(02)00392-x
10.1016/s0968-0004(98)01185-2
10.1016/j.celrep.2017.03.047
10.1038/nchembio860
10.7554/eLife.01503
10.1097/00019605-200009020-00021
10.1158/1055-9965.EPI-10-0555
10.1038/s41431-017-0033-y
10.1016/s0021-9258(18)47090-1
10.1038/s41588-019-0398-7
10.1038/5047
10.1016/j.ccell.2020.03.005
10.3389/fneur.2020.01005
10.1002/bies.950140103
10.1038/nrd2591
10.1093/nar/26.7.1567
10.1111/cge.14055
10.1038/ng.3740
10.4049/jimmunol.155.2.536
10.1177/0883073815627882
10.1016/j.gene.2007.04.027
10.1016/j.ejpn.2017.11.009
10.1101/gad.380906
10.1021/mp800051m
10.1371/journal.pone.0023320
10.1136/jmedgenet-2018-105625
10.1002/gcc.21996
10.1093/carcin/23.7.1103
10.1016/j.molcel.2011.08.042
10.1073/pnas.90.22.10489
10.1016/j.gene.2022.146287
10.29271/jcpsp.2022.02.236
10.1038/35020506
10.1038/nsmb.2796
10.1074/jbc.270.6.2620
10.1111/nan.12608
10.1016/S0140-6736(21)02017-1
10.1038/ng1966
10.1371/journal.pgen.1003897
10.1016/j.bioactmat.2022.03.039
10.1126/science.1178178
10.1038/nrc3130
10.1371/journal.pgen.1006864
10.1038/s41380-020-0725-5
ContentType Journal Article
Copyright Copyright © 2023 Roth, Kilpinen, Kurian and Barral.
Copyright © 2023 Roth, Kilpinen, Kurian and Barral. 2023 Roth, Kilpinen, Kurian and Barral
Copyright_xml – notice: Copyright © 2023 Roth, Kilpinen, Kurian and Barral.
– notice: Copyright © 2023 Roth, Kilpinen, Kurian and Barral. 2023 Roth, Kilpinen, Kurian and Barral
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fcell.2023.1090046
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Roth et al
EISSN 2296-634X
ExternalDocumentID oai_doaj_org_article_71449bf4d2024db3815b96038dbbd1e2
10_3389_fcell_2023_1090046
36923252
Genre Journal Article
Review
GrantInformation_xml – fundername: Wellcome Trust
GroupedDBID 53G
5VS
9T4
AAFWJ
ACGFS
ACXDI
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
ISR
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RPM
AAYXX
CITATION
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c469t-317101fe84243d4ca9bd29b686d89a6248dfe9c6c5e818f9ffaa379c084426833
IEDL.DBID RPM
ISSN 2296-634X
IngestDate Tue Oct 22 15:10:03 EDT 2024
Tue Sep 17 21:30:03 EDT 2024
Sat Oct 26 04:03:00 EDT 2024
Thu Nov 21 21:19:50 EST 2024
Sat Nov 02 12:16:31 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords epigenetics (chromatin remodeling)
small-activating RNA (saRNA)
histone lysine methyltransferases (HKMTs)
brain organoids
neurodevelopmental disorders (NDDs)
Language English
License Copyright © 2023 Roth, Kilpinen, Kurian and Barral.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-317101fe84243d4ca9bd29b686d89a6248dfe9c6c5e818f9ffaa379c084426833
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Katherine Athayde Teixeira De Carvalho, Pelé Pequeno Príncipe Research Institute, Brazil
Reviewed by: Luciane R. Cavalli, Pelé Pequeno Príncipe Research Institute, Brazil
Sue Fletcher, PYC Therapeutics, Australia
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009263/
PMID 36923252
PQID 2854429193
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_71449bf4d2024db3815b96038dbbd1e2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10009263
proquest_miscellaneous_2854429193
crossref_primary_10_3389_fcell_2023_1090046
pubmed_primary_36923252
PublicationCentury 2000
PublicationDate 2023-02-27
PublicationDateYYYYMMDD 2023-02-27
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-27
  day: 27
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in cell and developmental biology
PublicationTitleAlternate Front Cell Dev Biol
PublicationYear 2023
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Lancaster (B96) 2013; 501
Peinado (B132) 2004; 24
Thapar (B170) 2017; 4
Fear (B43) 2022; 821
Zhou (B186) 2019; 27
Yang (B182) 2008; 283
Stagi (B159) 2016; 64
Hashimoto (B64) 2021; 27
Strauss (B166) 2022; 28
Rea (B140) 2000; 406
Hiraide (B69) 2019; 4
Bradbury (B21) 1992; 14
Kim (B84) 2023; 19
Sheppard (B154) 1993
Guenther (B60) 2005; 102
Labonne (B93) 2016; 135
Pfister (B134) 2014; 7
Portnoy (B139) 2016; 26
Hempel (B67) 1968; 55
Steiner (B160) 2000; 9
Fimiani (B44) 2016; 6
Arents (B9) 1993; 90
Hu (B71) 2013; 33
Shen (B153) 2012; 19
Gregory (B58) 2007; 27
Masson (B112) 2022; 21
Wang (B175) 2016; 113
Miyazaki (B119) 2013; 9
Ruault (B148) 2002; 284
Lee (B102) 2009; 106
Brinkmeier (B22) 2015; 93
Turkmen (B172) 2012; 51
Fraga (B47) 2005; 37
Miura (B118) 2020; 38
Bianco-Miotto (B18) 2010; 19
Tanaka (B169) 2007; 397
Micale (B116) 2014; 35
Cau (B27) 2003; 130
Kerimoglu (B82) 2013; 33
Murray (B123) 1964; 3
Reebye (B141) 2018; 37
Wang (B177) 2021; 14
Howlin (B70) 2004; 45
Roberts (B146) 2020; 19
Hache (B62) 2016; 31
Pilarowski (B137) 2020; 145
Krzyzewska (B89) 2019; 11
Barlesi (B13) 2007; 25
Galet (B52) 2020; 11
Cantoni (B25) 1975; 44
Hirunagi (B68) 2021; 24
Zhao (B185) 2018; 1864
Koemans (B88) 2017; 13
Lavery (B98) 2020; 12
Iefremova (B74) 2017; 19
Birey (B19) 2017; 545
Niemi (B126) 2018; 562
Jo (B79) 2016; 19
Place (B138) 2010; 11
Alexis (B6) 2008; 5
Strahl (B163) 2000; 403
Yu (B183) 2019; 35
Aymard (B11) 2014; 21
Giandomenico (B53) 2021; 16
Tomizawa (B171) 2018; 145
Siano (B156) 2022; 14
Cameron (B24) 1999; 21
Fombonne (B46) 2003; 33
Faundes (B42) 2018; 102
Lee (B103) 2022; 16
Huang (B72) 2010; 5
Janowski (B77) 2006; 13
Meyer (B115) 2017; 49
Morris-Rosendahl (B121) 2020; 22
Sun (B167) 2005; 280
Gorman (B56) 2018; 22
Guvakova (B61) 1995; 270
Chen (B31) 1999; 284
Cif (B34) 2020; 143
Roston (B147) 2021; 58
De Rubeis (B38) 2014; 515
Matzke (B113) 2005; 6
Shi (B155) 2003; 422
Damasio (B37) 2021; 100
Singh (B158) 2022; 604
Heintzman (B66) 2007; 39
Ballestar (B12) 2002; 23
Ng (B125) 2010; 42
Bershteyn (B17) 2017; 20
Chaumeil (B28) 2006; 20
Finkelstein (B45) 1990; 1
Lebrun (B99) 2018; 26
Petros (B133) 2010; 9
Janowski (B78) 2007; 3
Pearson (B131) 2021; 12
Blakney (B20) 2019; 26
Brown (B23) 1994; 269
Cao (B26) 2010; 5
Grosz (B59) 2022; 10
Lessel (B104) 2020; 11
Park (B130) 2019; 10
Zech (B184) 2016; 99
Steward (B162) 2006; 13
Kummeling (B90) 2021; 26
Morin (B120) 2011; 476
Heintzman (B65) 2009; 459
Ciptasari (B36) 2020; 29
Straub (B165) 2022; 79
An (B7) 2011; 286
Kleefstra (B86) 2006; 79
Andrikakou (B8) 2022; 32
Pfluger (B135) 2008; 105
Stessman (B161) 2017; 49
Lee (B101) 2013; 2
Singh (B157) 2016; 19
Jones (B80) 2012; 91
Reynisdottir (B144) 2022; 18
Tunyasuvunakool (B173) 2021; 596
Pichot (B136) 1986; 142
Adam (B1) 2019; 56
Cheema (B29) 2022; 32
Ahn (B3) 2021; 10
Paik (B129) 1967; 27
Lister (B109) 2013; 341
Salinas (B149) 2020; 46
Tachibana (B168) 2001; 276
Frances (B48) 2022; 16
Xu (B181) 2019; 51
Kuroki (B92) 1981; 99
Desrosiers (B40) 1988; 263
Michurina (B117) 2022; 41
Liang (B107) 2014; 42
Aletta (B5) 1998; 23
Voutila (B174) 2017; 25
Bergmann (B16) 2018; 13
Ciolfi (B35) 2021; 13
Kleefstra (B87) 2009; 46
Kuo (B91) 2011; 44
Schwartz (B152) 2008; 15
Lanford (B97) 2010; 327
Dharmarajan (B41) 2012; 287
Benveniste (B15) 1995; 155
Lederer (B100) 2012; 90
Watanabe (B179) 2011; 6
Macrae (B110) 2022; 24
Sarker (B150) 2020; 26
Will (B180) 2014; 25
Wang (B178) 2022; 39
Gala (B51) 2018; 37
Gilbert (B54) 2004; 10
Li (B105) 2006; 103
Kerimoglu (B83) 2017; 20
Alam (B4) 2020; 37
(B39) 2017; 542
Greer (B57) 2012; 13
Attarbaschi (B10) 2022
Liang (B108) 2015; 43
Jakovcevski (B76) 2015; 35
Chen (B30) 2014; 25
Giles (B55) 1998; 26
Ismail (B75) 2019; 32
Pai (B128) 2017; 20
Meng (B114) 2016; 44
Hughes (B73) 2004; 13
Okamoto (B127) 2017; 173
Reebye (B142) 2014; 59
Wang (B176) 2004; 431
Baylin (B14) 2011; 11
Fuks (B49) 2000; 24
Adam (B2) 1993
Lachner (B94) 2002; 14
Nagahama (B124) 2020; 32
Martynoga (B111) 2005; 283
Schalk (B151) 2022; 59
Li (B106) 2020; 28
Hanashima (B63) 2004; 303
Kang (B81) 2012; 72
Kim (B85) 2015; 77
Cho (B33) 2007; 282
Strahl (B164) 1999; 96
Richmond (B145) 1984; 311
Mukai (B122) 2019; 104
Fumagalli (B50) 2022; 399
Lancaster (B95) 2017; 35
Cheng (B32) 2001; 20
Reichard (B143) 2021; 15
References_xml – volume: 545
  start-page: 54
  year: 2017
  ident: B19
  article-title: Assembly of functionally integrated human forebrain spheroids
  publication-title: Nature
  doi: 10.1038/nature22330
  contributor:
    fullname: Birey
– volume: 459
  start-page: 108
  year: 2009
  ident: B65
  article-title: Histone modifications at human enhancers reflect global cell-type-specific gene expression
  publication-title: Nature
  doi: 10.1038/nature07829
  contributor:
    fullname: Heintzman
– volume: 90
  start-page: 119
  year: 2012
  ident: B100
  article-title: Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome
  publication-title: Am. J. Hum. Genet.
  doi: 10.1016/j.ajhg.2011.11.021
  contributor:
    fullname: Lederer
– volume: 44
  start-page: 2274
  year: 2016
  ident: B114
  article-title: Small activating RNA binds to the genomic target site in a seed-region-dependent manner
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkw076
  contributor:
    fullname: Meng
– volume: 43
  start-page: 2927
  year: 2015
  ident: B108
  article-title: Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv143
  contributor:
    fullname: Liang
– volume: 39
  start-page: 110790
  year: 2022
  ident: B178
  article-title: Loss-of-function variants in the schizophrenia risk gene SETD1A alter neuronal network activity in human neurons through the cAMP/PKA pathway
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2022.110790
  contributor:
    fullname: Wang
– volume: 25
  start-page: 4358
  year: 2007
  ident: B13
  article-title: Global histone modifications predict prognosis of resected non small-cell lung cancer
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.11.2599
  contributor:
    fullname: Barlesi
– volume: 13
  start-page: 852
  year: 2006
  ident: B162
  article-title: Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb1131
  contributor:
    fullname: Steward
– volume: 59
  start-page: 965
  year: 2022
  ident: B151
  article-title: De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability
  publication-title: J. Med. Genet.
  doi: 10.1136/jmedgenet-2021-107751
  contributor:
    fullname: Schalk
– volume: 604
  start-page: 509
  year: 2022
  ident: B158
  article-title: Rare coding variants in ten genes confer substantial risk for schizophrenia
  publication-title: Nature
  doi: 10.1038/s41586-022-04556-w
  contributor:
    fullname: Singh
– volume: 35
  start-page: 5097
  year: 2015
  ident: B76
  article-title: Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3004-14.2015
  contributor:
    fullname: Jakovcevski
– volume: 143
  start-page: 3242
  year: 2020
  ident: B34
  article-title: KMT2B-related disorders: Expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation
  publication-title: Brain
  doi: 10.1093/brain/awaa304
  contributor:
    fullname: Cif
– volume: 24
  start-page: 6
  year: 2022
  ident: B110
  article-title: Regulation, functions and transmission of bivalent chromatin during mammalian development
  publication-title: Nat. Rev. Mol. Cell. Biol.
  doi: 10.1038/s41580-022-00518-2
  contributor:
    fullname: Macrae
– volume: 21
  start-page: 1110
  year: 2022
  ident: B112
  article-title: Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): Secondary analyses from an open-label trial
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(22)00339-8
  contributor:
    fullname: Masson
– volume: 32
  start-page: 486
  year: 2022
  ident: B8
  article-title: Enhancing SIRT1 gene expression using small activating RNAs: A novel approach for reversing metabolic syndrome
  publication-title: Nucleic Acid. Ther.
  doi: 10.1089/nat.2021.0115
  contributor:
    fullname: Andrikakou
– volume: 19
  start-page: 248
  year: 2016
  ident: B79
  article-title: Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons
  publication-title: Cell. Stem Cell.
  doi: 10.1016/j.stem.2016.07.005
  contributor:
    fullname: Jo
– volume: 501
  start-page: 373
  year: 2013
  ident: B96
  article-title: Cerebral organoids model human brain development and microcephaly
  publication-title: Nature
  doi: 10.1038/nature12517
  contributor:
    fullname: Lancaster
– volume: 6
  start-page: 39311
  year: 2016
  ident: B44
  article-title: RNA activation of haploinsufficient Foxg1 gene in murine neocortex
  publication-title: Sci. Rep.
  doi: 10.1038/srep39311
  contributor:
    fullname: Fimiani
– volume: 142
  start-page: 489
  year: 1986
  ident: B136
  article-title: DSM-III: The 3d edition of the diagnostic and statistical manual of mental disorders from the American psychiatric association
  publication-title: Rev. Neurol. Paris.
  contributor:
    fullname: Pichot
– volume: 93
  start-page: 121
  year: 2015
  ident: B22
  article-title: The histone methyltransferase gene absent, small, or homeotic discs-1 like is required for normal hox gene expression and fertility in mice
  publication-title: Biol. Reprod.
  doi: 10.1095/biolreprod.115.131516
  contributor:
    fullname: Brinkmeier
– volume: 77
  start-page: 66
  year: 2015
  ident: B85
  article-title: Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2014.11.001
  contributor:
    fullname: Kim
– volume: 15
  start-page: 776809
  year: 2021
  ident: B143
  article-title: The epigenome in neurodevelopmental disorders
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2021.776809
  contributor:
    fullname: Reichard
– volume: 96
  start-page: 14967
  year: 1999
  ident: B164
  article-title: Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.96.26.14967
  contributor:
    fullname: Strahl
– volume: 46
  start-page: 598
  year: 2009
  ident: B87
  article-title: Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype
  publication-title: J. Med. Genet.
  doi: 10.1136/jmg.2008.062950
  contributor:
    fullname: Kleefstra
– volume: 7
  start-page: 2006
  year: 2014
  ident: B134
  article-title: SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2014.05.026
  contributor:
    fullname: Pfister
– start-page: JCO2201297
  year: 2022
  ident: B10
  article-title: Outcomes of childhood noninfant acute lymphoblastic leukemia with 11q23/kmt2a rearrangements in a modern therapy era: A retrospective international study
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.22.01297
  contributor:
    fullname: Attarbaschi
– volume: 99
  start-page: 570
  year: 1981
  ident: B92
  article-title: A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation
  publication-title: J. Pediatr.
  doi: 10.1016/s0022-3476(81)80256-9
  contributor:
    fullname: Kuroki
– volume: 32
  start-page: 108126
  year: 2020
  ident: B124
  article-title: Setd1a insufficiency in mice attenuates excitatory synaptic function and recapitulates schizophrenia-related behavioral abnormalities
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2020.108126
  contributor:
    fullname: Nagahama
– volume: 4
  start-page: 339
  year: 2017
  ident: B170
  article-title: Neurodevelopmental disorders
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)30376-5
  contributor:
    fullname: Thapar
– volume: 14
  start-page: 286
  year: 2002
  ident: B94
  article-title: The many faces of histone lysine methylation
  publication-title: Curr. Opin. Cell. Biol.
  doi: 10.1016/s0955-0674(02)00335-6
  contributor:
    fullname: Lachner
– volume: 105
  start-page: 9793
  year: 2008
  ident: B135
  article-title: Sirt1 protects against high-fat diet-induced metabolic damage
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0802917105
  contributor:
    fullname: Pfluger
– volume: 27
  start-page: 479
  year: 1967
  ident: B129
  article-title: E-N-dimethyllysine in histones
  publication-title: Biochem.Biophys. Res. Commun.
  doi: 10.1016/s0006-291x(67)80010-x
  contributor:
    fullname: Paik
– volume: 10
  start-page: 2527
  year: 2021
  ident: B3
  article-title: Exendin-4 pretreatment attenuates kainic acid-induced hippocampal neuronal death
  publication-title: Cells
  doi: 10.3390/cells10102527
  contributor:
    fullname: Ahn
– volume: 276
  start-page: 25309
  year: 2001
  ident: B168
  article-title: Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M101914200
  contributor:
    fullname: Tachibana
– volume: 22
  start-page: 65
  year: 2020
  ident: B121
  article-title: Neurodevelopmental disorders-the history and future of a diagnostic concept
  publication-title: Dialogues Clin. Neurosci.
  doi: 10.31887/DCNS.2020.22.1/macrocq
  contributor:
    fullname: Morris-Rosendahl
– volume: 6
  start-page: 24
  year: 2005
  ident: B113
  article-title: RNAi-mediated pathways in the nucleus
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1500
  contributor:
    fullname: Matzke
– volume: 79
  start-page: 232
  year: 2022
  ident: B165
  article-title: Neurodevelopmental disorders among publicly or privately insured children in the United States
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2021.3815
  contributor:
    fullname: Straub
– volume: 55
  start-page: 37
  year: 1968
  ident: B67
  article-title: Epsilon-N-trimethyllysine, a new amino acid in histones
  publication-title: Naturwissenschaften
  doi: 10.1007/BF00593411
  contributor:
    fullname: Hempel
– volume: 283
  start-page: 113
  year: 2005
  ident: B111
  article-title: Foxg1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis
  publication-title: Dev. Biol.
  doi: 10.1016/j.ydbio.2005.04.005
  contributor:
    fullname: Martynoga
– volume: 25
  start-page: 555
  year: 2014
  ident: B180
  article-title: Combinatorial haplo-deficient tumor suppression in 7q-deficient myelodysplastic syndrome and acute myeloid leukemia
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccr.2014.04.018
  contributor:
    fullname: Will
– volume: 284
  start-page: 2174
  year: 1999
  ident: B31
  article-title: Regulation of transcription by a protein methyltransferase
  publication-title: Science
  doi: 10.1126/science.284.5423.2174
  contributor:
    fullname: Chen
– volume: 104
  start-page: 471
  year: 2019
  ident: B122
  article-title: Recapitulation and reversal of schizophrenia-related phenotypes in setd1a-deficient mice
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.09.014
  contributor:
    fullname: Mukai
– volume: 282
  start-page: 20395
  year: 2007
  ident: B33
  article-title: PTIP associates with MLL3-and MLL4-containing histone H3 lysine 4 methyltransferase complex
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M701574200
  contributor:
    fullname: Cho
– volume: 37
  start-page: 4692
  year: 2018
  ident: B51
  article-title: KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0273-5
  contributor:
    fullname: Gala
– volume: 106
  start-page: 8513
  year: 2009
  ident: B102
  article-title: A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0902873106
  contributor:
    fullname: Lee
– volume: 28
  start-page: 1141
  year: 2020
  ident: B106
  article-title: Crystal structure of MLL2 complex guides the identification of a methylation site on P53 catalyzed by KMT2 family methyltransferases
  publication-title: Structure
  doi: 10.1016/j.str.2020.07.002
  contributor:
    fullname: Li
– volume: 19
  start-page: 673
  year: 2020
  ident: B146
  article-title: Advances in oligonucleotide drug delivery
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-020-0075-7
  contributor:
    fullname: Roberts
– volume-title: GeneReviews((R))
  year: 1993
  ident: B2
  article-title: Kabuki syndrome
  contributor:
    fullname: Adam
– volume: 476
  start-page: 298
  year: 2011
  ident: B120
  article-title: Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
  publication-title: Nature
  doi: 10.1038/nature10351
  contributor:
    fullname: Morin
– volume: 72
  start-page: 5069
  year: 2012
  ident: B81
  article-title: Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-1871
  contributor:
    fullname: Kang
– volume: 113
  start-page: 11871
  year: 2016
  ident: B175
  article-title: Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1606857113
  contributor:
    fullname: Wang
– volume: 37
  start-page: 391
  year: 2005
  ident: B47
  article-title: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
  publication-title: Nat. Genet.
  doi: 10.1038/ng1531
  contributor:
    fullname: Fraga
– volume: 32
  start-page: 611
  year: 2019
  ident: B75
  article-title: What are neurodevelopmental disorders?
  publication-title: Curr. Opin. Neurol.
  doi: 10.1097/WCO.0000000000000710
  contributor:
    fullname: Ismail
– volume: 27
  start-page: 5961
  year: 2021
  ident: B64
  article-title: Upregulation of C/EBPα inhibits suppressive activity of myeloid cells and potentiates antitumor response in mice and patients with cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-21-0986
  contributor:
    fullname: Hashimoto
– volume: 13
  start-page: 787
  year: 2006
  ident: B77
  article-title: Involvement of AGO1 and AGO2 in mammalian transcriptional silencing
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb1140
  contributor:
    fullname: Janowski
– volume: 25
  start-page: 2705
  year: 2017
  ident: B174
  article-title: Development and mechanism of small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver cancer
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.07.018
  contributor:
    fullname: Voutila
– volume: 102
  start-page: 8603
  year: 2005
  ident: B60
  article-title: Global and Hox-specific roles for the MLL1 methyltransferase
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0503072102
  contributor:
    fullname: Guenther
– volume: 42
  start-page: 7819
  year: 2014
  ident: B107
  article-title: TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gku484
  contributor:
    fullname: Liang
– volume: 145
  start-page: dev169102
  year: 2018
  ident: B171
  article-title: Kmt2b conveys monovalent and bivalent H3K4me3 in mouse spermatogonial stem cells at germline and embryonic promoters
  publication-title: Development
  doi: 10.1242/dev.169102
  contributor:
    fullname: Tomizawa
– volume: 145
  start-page: 982
  year: 2020
  ident: B137
  article-title: Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2019.11.034
  contributor:
    fullname: Pilarowski
– volume: 20
  start-page: 3814
  year: 2001
  ident: B32
  article-title: Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204505
  contributor:
    fullname: Cheng
– volume: 5
  start-page: e14102
  year: 2010
  ident: B26
  article-title: An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0014102
  contributor:
    fullname: Cao
– volume: 135
  start-page: 757
  year: 2016
  ident: B93
  article-title: An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability
  publication-title: Hum. Genet.
  doi: 10.1007/s00439-016-1668-4
  contributor:
    fullname: Labonne
– volume: 44
  start-page: 435
  year: 1975
  ident: B25
  article-title: Biological methylation- selected aspects
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.bi.44.070175.002251
  contributor:
    fullname: Cantoni
– volume: 3
  start-page: 10
  year: 1964
  ident: B123
  article-title: The occurrence of epsilon-N-methyl lysine in histones
  publication-title: Biochemistry
  doi: 10.1021/bi00889a003
  contributor:
    fullname: Murray
– volume: 59
  start-page: 216
  year: 2014
  ident: B142
  article-title: Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo
  publication-title: Hepatology
  doi: 10.1002/hep.26669
  contributor:
    fullname: Reebye
– volume: 29
  start-page: R42
  year: 2020
  ident: B36
  article-title: The phenomenal epigenome in neurodevelopmental disorders
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddaa175
  contributor:
    fullname: Ciptasari
– volume: 26
  start-page: 3936
  year: 2020
  ident: B150
  article-title: MTL-CEBPA, a small activating RNA therapeutic upregulating C/EBP-alpha, in patients with advanced liver cancer: A first-in-human, multicenter, open-label, phase I trial
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-0414
  contributor:
    fullname: Sarker
– volume: 33
  start-page: 4745
  year: 2013
  ident: B71
  article-title: The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01181-13
  contributor:
    fullname: Hu
– volume: 13
  start-page: 2827
  year: 2018
  ident: B16
  article-title: Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics
  publication-title: Nat. Protoc.
  doi: 10.1038/s41596-018-0066-x
  contributor:
    fullname: Bergmann
– volume: 28
  start-page: 1381
  year: 2022
  ident: B166
  article-title: Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: The phase III SPR1NT trial
  publication-title: Nat. Med.
  doi: 10.1038/s41591-022-01866-4
  contributor:
    fullname: Strauss
– volume: 58
  start-page: 196
  year: 2021
  ident: B147
  article-title: SETD1B-associated neurodevelopmental disorder
  publication-title: J. Med. Genet.
  doi: 10.1136/jmedgenet-2019-106756
  contributor:
    fullname: Roston
– volume: 280
  start-page: 35261
  year: 2005
  ident: B167
  article-title: Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M504012200
  contributor:
    fullname: Sun
– volume: 10
  start-page: 4589
  year: 2004
  ident: B54
  article-title: The clinical application of targeting cancer through histone acetylation and hypomethylation
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-03-0297
  contributor:
    fullname: Gilbert
– volume: 596
  start-page: 590
  year: 2021
  ident: B173
  article-title: Highly accurate protein structure prediction for the human proteome
  publication-title: Nature
  doi: 10.1038/s41586-021-03828-1
  contributor:
    fullname: Tunyasuvunakool
– volume: 15
  start-page: 842
  year: 2008
  ident: B152
  article-title: Antisense transcripts are targets for activating small RNAs
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.1444
  contributor:
    fullname: Schwartz
– volume: 64
  start-page: 345
  year: 2016
  ident: B159
  article-title: Epigenetic control of the immune system: A lesson from Kabuki syndrome
  publication-title: Immunol. Res.
  doi: 10.1007/s12026-015-8707-4
  contributor:
    fullname: Stagi
– volume: 431
  start-page: 873
  year: 2004
  ident: B176
  article-title: Role of histone H2A ubiquitination in Polycomb silencing
  publication-title: Nature
  doi: 10.1038/nature02985
  contributor:
    fullname: Wang
– volume: 49
  start-page: 515
  year: 2017
  ident: B161
  article-title: Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3792
  contributor:
    fullname: Stessman
– volume: 12
  start-page: 10
  year: 2020
  ident: B98
  article-title: KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: An emerging class of congenital regulopathies
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-019-0802-2
  contributor:
    fullname: Lavery
– volume: 11
  start-page: 518
  year: 2010
  ident: B138
  article-title: Defining features and exploring chemical modifications to manipulate RNAa activity
  publication-title: Curr. Pharm. Biotechnol.
  doi: 10.2174/138920110791591463
  contributor:
    fullname: Place
– volume: 1
  start-page: 228
  year: 1990
  ident: B45
  article-title: Methionine metabolism in mammals
  publication-title: J. Nutr. Biochem.
  doi: 10.1016/0955-2863(90)90070-2
  contributor:
    fullname: Finkelstein
– volume: 91
  start-page: 358
  year: 2012
  ident: B80
  article-title: De novo mutations in MLL cause Wiedemann-Steiner syndrome
  publication-title: Am. J. Hum. Genet.
  doi: 10.1016/j.ajhg.2012.06.008
  contributor:
    fullname: Jones
– volume: 19
  start-page: 571
  year: 2016
  ident: B157
  article-title: Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4267
  contributor:
    fullname: Singh
– volume: 13
  start-page: 343
  year: 2012
  ident: B57
  article-title: Histone methylation: A dynamic mark in health, disease and inheritance
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg3173
  contributor:
    fullname: Greer
– volume: 102
  start-page: 175
  year: 2018
  ident: B42
  article-title: Histone lysine methylases and demethylases in the landscape of human developmental disorders
  publication-title: Am. J. Hum. Genet.
  doi: 10.1016/j.ajhg.2017.11.013
  contributor:
    fullname: Faundes
– volume: 542
  start-page: 433
  year: 2017
  ident: B39
  article-title: Prevalence and architecture of de novo mutations in developmental disorders
  publication-title: Nature
  doi: 10.1038/nature21062
– volume: 27
  start-page: 8466
  year: 2007
  ident: B58
  article-title: Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00993-07
  contributor:
    fullname: Gregory
– volume: 14
  start-page: 131
  year: 2022
  ident: B156
  article-title: De novo mutation in KMT2C manifesting as Kleefstra syndrome 2: Case report and literature review
  publication-title: Pediatr. Rep.
  doi: 10.3390/pediatric14010019
  contributor:
    fullname: Siano
– volume: 13
  start-page: 157
  year: 2021
  ident: B35
  article-title: Childhood-onset dystonia-causing KMT2B variants result in a distinctive genomic hypermethylation profile
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-021-01145-y
  contributor:
    fullname: Ciolfi
– volume: 103
  start-page: 17337
  year: 2006
  ident: B105
  article-title: Small dsRNAs induce transcriptional activation in human cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0607015103
  contributor:
    fullname: Li
– volume: 35
  start-page: 841
  year: 2014
  ident: B116
  article-title: Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients
  publication-title: Hum. Mutat.
  doi: 10.1002/humu.22547
  contributor:
    fullname: Micale
– volume: 25
  start-page: 652
  year: 2014
  ident: B30
  article-title: MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccr.2014.03.016
  contributor:
    fullname: Chen
– volume: 16
  start-page: 579
  year: 2021
  ident: B53
  article-title: Generation and long-term culture of advanced cerebral organoids for studying later stages of neural development
  publication-title: Nat. Protoc.
  doi: 10.1038/s41596-020-00433-w
  contributor:
    fullname: Giandomenico
– volume: 45
  start-page: 212
  year: 2004
  ident: B70
  article-title: Adult outcome for children with autism
  publication-title: J. Child. Psychol. Psychiatry
  doi: 10.1111/j.1469-7610.2004.00215.x
  contributor:
    fullname: Howlin
– volume: 5
  start-page: e8848
  year: 2010
  ident: B72
  article-title: RNAa is conserved in mammalian cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0008848
  contributor:
    fullname: Huang
– volume: 13
  start-page: 587
  year: 2004
  ident: B73
  article-title: Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus
  publication-title: Mol. Cell.
  doi: 10.1016/s1097-2765(04)00081-4
  contributor:
    fullname: Hughes
– volume: 35
  start-page: 659
  year: 2017
  ident: B95
  article-title: Guided self-organization and cortical plate formation in human brain organoids
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3906
  contributor:
    fullname: Lancaster
– volume: 38
  start-page: 1421
  year: 2020
  ident: B118
  article-title: Generation of human striatal organoids and cortico-striatal assembloids from human pluripotent stem cells
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-020-00763-w
  contributor:
    fullname: Miura
– volume: 173
  start-page: 1644
  year: 2017
  ident: B127
  article-title: Novel MCA/ID syndrome with ASH1L mutation
  publication-title: Am. J. Med. Genet. A
  doi: 10.1002/ajmg.a.38193
  contributor:
    fullname: Okamoto
– volume: 403
  start-page: 41
  year: 2000
  ident: B163
  article-title: The language of covalent histone modifications
  publication-title: Nature
  doi: 10.1038/47412
  contributor:
    fullname: Strahl
– volume: 283
  start-page: 12085
  year: 2008
  ident: B182
  article-title: Preferential dimethylation of histone H4 lysine 20 by Suv4-20
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M707974200
  contributor:
    fullname: Yang
– volume: 341
  start-page: 1237905
  year: 2013
  ident: B109
  article-title: Global epigenomic reconfiguration during mammalian brain development
  publication-title: Science
  doi: 10.1126/science.1237905
  contributor:
    fullname: Lister
– volume: 11
  start-page: 156
  year: 2019
  ident: B89
  article-title: A genome-wide DNA methylation signature for SETD1B-related syndrome
  publication-title: Clin. Epigenetics
  doi: 10.1186/s13148-019-0749-3
  contributor:
    fullname: Krzyzewska
– volume: 37
  start-page: 3216
  year: 2018
  ident: B141
  article-title: Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0126-2
  contributor:
    fullname: Reebye
– volume: 99
  start-page: 1377
  year: 2016
  ident: B184
  article-title: Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2B, results in early-onset generalized dystonia
  publication-title: Am. J. Hum. Genet.
  doi: 10.1016/j.ajhg.2016.10.010
  contributor:
    fullname: Zech
– volume: 515
  start-page: 209
  year: 2014
  ident: B38
  article-title: Synaptic, transcriptional and chromatin genes disrupted in autism
  publication-title: Nature
  doi: 10.1038/nature13772
  contributor:
    fullname: De Rubeis
– volume: 422
  start-page: 735
  year: 2003
  ident: B155
  article-title: Coordinated histone modifications mediated by a CtBP co-repressor complex
  publication-title: Nature
  doi: 10.1038/nature01550
  contributor:
    fullname: Shi
– volume: 303
  start-page: 56
  year: 2004
  ident: B63
  article-title: Foxg1 suppresses early cortical cell fate
  publication-title: Science
  doi: 10.1126/science.1090674
  contributor:
    fullname: Hanashima
– volume: 12
  start-page: 4251
  year: 2021
  ident: B131
  article-title: Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-24524-8
  contributor:
    fullname: Pearson
– volume: 286
  start-page: 8369
  year: 2011
  ident: B7
  article-title: Crystal structure of the human histone methyltransferase ASH1L catalytic domain and its implications for the regulatory mechanism
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.203380
  contributor:
    fullname: An
– volume: 24
  start-page: 88
  year: 2000
  ident: B49
  article-title: DNA methyltransferase Dnmt1 associates with histone deacetylase activity
  publication-title: Nat. Genet.
  doi: 10.1038/71750
  contributor:
    fullname: Fuks
– volume: 24
  start-page: 1
  year: 2021
  ident: B68
  article-title: Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2021.02.007
  contributor:
    fullname: Hirunagi
– volume: 16
  start-page: 27
  year: 2022
  ident: B103
  article-title: Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders
  publication-title: Child Adolesc. Psychiatry Ment. Health
  contributor:
    fullname: Lee
– volume: 1864
  start-page: 2108
  year: 2018
  ident: B185
  article-title: 19q13.12 microdeletion syndrome fibroblasts display abnormal storage of cholesterol and sphingolipids in the endo-lysosomal system
  publication-title: Biochim. Biophys. Acta Mol. Basis Dis.
  doi: 10.1016/j.bbadis.2018.03.020
  contributor:
    fullname: Zhao
– volume: 79
  start-page: 370
  year: 2006
  ident: B86
  article-title: Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome
  publication-title: Am. J. Hum. Genet.
  doi: 10.1086/505693
  contributor:
    fullname: Kleefstra
– volume-title: GeneReviews((R))
  year: 1993
  ident: B154
  article-title: Wiedemann-steiner syndrome
  contributor:
    fullname: Sheppard
– volume: 287
  start-page: 27275
  year: 2012
  ident: B41
  article-title: Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.364125
  contributor:
    fullname: Dharmarajan
– volume: 130
  start-page: 2455
  year: 2003
  ident: B27
  article-title: Ash1a and Neurogenin1 function downstream of Floating head to regulate epiphysial neurogenesis
  publication-title: Development
  doi: 10.1242/dev.00452
  contributor:
    fullname: Cau
– volume: 35
  start-page: 1045
  year: 2019
  ident: B183
  article-title: De novo and inherited SETD1A variants in early-onset epilepsy
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-019-00400-w
  contributor:
    fullname: Yu
– volume: 263
  start-page: 4686
  year: 1988
  ident: B40
  article-title: Methylation of Drosophila histones at proline, lysine, and arginine residues during heat shock
  publication-title: J. Biol. Chem.
  doi: 10.1016/s0021-9258(18)68837-4
  contributor:
    fullname: Desrosiers
– volume: 10
  start-page: e1923
  year: 2022
  ident: B59
  article-title: A novel synonymous KMT2B variant in a patient with dystonia causes aberrant splicing
  publication-title: Mol. Genet. Genomic Med.
  doi: 10.1002/mgg3.1923
  contributor:
    fullname: Grosz
– volume: 4
  start-page: 476
  year: 2019
  ident: B69
  article-title: De novo variants in SETD1B cause intellectual disability, autism spectrum disorder, and epilepsy with myoclonic absences
  publication-title: Epilepsia Open
  doi: 10.1002/epi4.12339
  contributor:
    fullname: Hiraide
– volume: 20
  start-page: 2693
  year: 2017
  ident: B128
  article-title: Set2 methyltransferase facilitates DNA replication and promotes genotoxic stress responses through MBF-dependent transcription
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2017.08.058
  contributor:
    fullname: Pai
– volume: 18
  start-page: e1010278
  year: 2022
  ident: B144
  article-title: Missense variants causing Wiedemann-Steiner syndrome preferentially occur in the KMT2A-CXXC domain and are accurately classified using AlphaFold2
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1010278
  contributor:
    fullname: Reynisdottir
– volume: 33
  start-page: 3452
  year: 2013
  ident: B82
  article-title: Histone-methyltransferase MLL2 (KMT2B) is required for memory formation in mice
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3356-12.2013
  contributor:
    fullname: Kerimoglu
– volume: 11
  start-page: 5797
  year: 2020
  ident: B104
  article-title: Germline AGO2 mutations impair RNA interference and human neurological development
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19572-5
  contributor:
    fullname: Lessel
– volume: 10
  start-page: 5540
  year: 2019
  ident: B130
  article-title: Cryo-EM structure of the human MLL1 core complex bound to the nucleosome
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-13550-2
  contributor:
    fullname: Park
– volume: 19
  start-page: 367
  year: 2012
  ident: B153
  article-title: Nanovector delivery of siRNA for cancer therapy
  publication-title: Cancer Gene Ther.
  doi: 10.1038/cgt.2012.22
  contributor:
    fullname: Shen
– volume: 26
  start-page: 363
  year: 2019
  ident: B20
  article-title: Inside out: Optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
  publication-title: Gene Ther.
  doi: 10.1038/s41434-019-0095-2
  contributor:
    fullname: Blakney
– volume: 41
  start-page: e106459
  year: 2022
  ident: B117
  article-title: Postnatal expression of the lysine methyltransferase SETD1B is essential for learning and the regulation of neuron-enriched genes
  publication-title: EMBO J.
  doi: 10.15252/embj.2020106459
  contributor:
    fullname: Michurina
– volume: 24
  start-page: 306
  year: 2004
  ident: B132
  article-title: Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.24.1.306-319.2004
  contributor:
    fullname: Peinado
– volume: 26
  start-page: 320
  year: 2016
  ident: B139
  article-title: saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription
  publication-title: Cell. Res.
  doi: 10.1038/cr.2016.22
  contributor:
    fullname: Portnoy
– volume: 16
  start-page: 27
  year: 2022
  ident: B48
  article-title: Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: A systematic review in accordance with the PRISMA criteria
  publication-title: Child. Adolesc. Psychiatry Ment. Health
  doi: 10.1186/s13034-022-00462-1
  contributor:
    fullname: Frances
– volume: 311
  start-page: 532
  year: 1984
  ident: B145
  article-title: Structure of the nucleosome core particle at 7 A resolution
  publication-title: Nature
  doi: 10.1038/311532a0
  contributor:
    fullname: Richmond
– volume: 14
  start-page: 772000
  year: 2021
  ident: B177
  article-title: SETD1A mediated H3K4 methylation and its role in neurodevelopmental and neuropsychiatric disorders
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2021.772000
  contributor:
    fullname: Wang
– volume: 20
  start-page: 538
  year: 2017
  ident: B83
  article-title: KMT2A and KMT2B mediate memory function by affecting distinct genomic regions
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2017.06.072
  contributor:
    fullname: Kerimoglu
– volume: 562
  start-page: 268
  year: 2018
  ident: B126
  article-title: Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
  publication-title: Nature
  doi: 10.1038/s41586-018-0566-4
  contributor:
    fullname: Niemi
– volume: 27
  start-page: 999
  year: 2019
  ident: B186
  article-title: Anti-inflammatory activity of MTL-CEBPA, a small activating RNA drug, in LPS-stimulated monocytes and humanized mice
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2019.02.018
  contributor:
    fullname: Zhou
– volume: 20
  start-page: 435
  year: 2017
  ident: B17
  article-title: Human iPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia
  publication-title: Cell. Stem Cell.
  doi: 10.1016/j.stem.2016.12.007
  contributor:
    fullname: Bershteyn
– volume: 33
  start-page: 365
  year: 2003
  ident: B46
  article-title: Epidemiological surveys of autism and other pervasive developmental disorders: An update
  publication-title: J. Autism Dev. Disord.
  doi: 10.1023/a:1025054610557
  contributor:
    fullname: Fombonne
– volume: 42
  start-page: 790
  year: 2010
  ident: B125
  article-title: Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome
  publication-title: Nat. Genet.
  doi: 10.1038/ng.646
  contributor:
    fullname: Ng
– volume: 284
  start-page: 73
  year: 2002
  ident: B148
  article-title: MLL3, a new human member of the TRX:MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia
  publication-title: Gene
  doi: 10.1016/s0378-1119(02)00392-x
  contributor:
    fullname: Ruault
– volume: 23
  start-page: 89
  year: 1998
  ident: B5
  article-title: Protein methylation: A signal event in post-translational modification
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/s0968-0004(98)01185-2
  contributor:
    fullname: Aletta
– volume: 19
  start-page: 50
  year: 2017
  ident: B74
  article-title: An organoid-based model of cortical development identifies non-cell-autonomous defects in wnt signaling contributing to miller-dieker syndrome
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2017.03.047
  contributor:
    fullname: Iefremova
– volume: 3
  start-page: 166
  year: 2007
  ident: B78
  article-title: Activating gene expression in mammalian cells with promoter-targeted duplex RNAs
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio860
  contributor:
    fullname: Janowski
– volume: 2
  start-page: e01503
  year: 2013
  ident: B101
  article-title: H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation
  publication-title: Elife
  doi: 10.7554/eLife.01503
  contributor:
    fullname: Lee
– volume: 9
  start-page: 155
  year: 2000
  ident: B160
  article-title: Growth deficiency, mental retardation and unusual facies
  publication-title: Clin. Dysmorphol.
  doi: 10.1097/00019605-200009020-00021
  contributor:
    fullname: Steiner
– volume: 19
  start-page: 2611
  year: 2010
  ident: B18
  article-title: Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-10-0555
  contributor:
    fullname: Bianco-Miotto
– volume: 26
  start-page: 107
  year: 2018
  ident: B99
  article-title: Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome
  publication-title: Eur. J. Hum. Genet.
  doi: 10.1038/s41431-017-0033-y
  contributor:
    fullname: Lebrun
– volume: 269
  start-page: 26801
  year: 1994
  ident: B23
  article-title: Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding
  publication-title: J. Biol. Chem.
  doi: 10.1016/s0021-9258(18)47090-1
  contributor:
    fullname: Brown
– volume: 51
  start-page: 844
  year: 2019
  ident: B181
  article-title: SETD2 regulates the maternal epigenome, genomic imprinting and embryonic development
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-019-0398-7
  contributor:
    fullname: Xu
– volume: 21
  start-page: 103
  year: 1999
  ident: B24
  article-title: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
  publication-title: Nat. Genet.
  doi: 10.1038/5047
  contributor:
    fullname: Cameron
– volume: 37
  start-page: 599
  year: 2020
  ident: B4
  article-title: KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccell.2020.03.005
  contributor:
    fullname: Alam
– volume: 11
  start-page: 1005
  year: 2020
  ident: B52
  article-title: Patient-derived midbrain organoids to explore the molecular basis of Parkinson's disease
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2020.01005
  contributor:
    fullname: Galet
– volume: 14
  start-page: 9
  year: 1992
  ident: B21
  article-title: Reversible histone modifications and the chromosome cell cycle
  publication-title: Bioessays
  doi: 10.1002/bies.950140103
  contributor:
    fullname: Bradbury
– volume: 9
  start-page: 615
  year: 2010
  ident: B133
  article-title: Strategies in the design of nanoparticles for therapeutic applications
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2591
  contributor:
    fullname: Petros
– volume: 26
  start-page: 1567
  year: 1998
  ident: B55
  article-title: Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/26.7.1567
  contributor:
    fullname: Giles
– volume: 100
  start-page: 743
  year: 2021
  ident: B37
  article-title: Novel KMT2B mutation causes cerebellar ataxia: Expanding the clinical phenotype
  publication-title: Clin. Genet.
  doi: 10.1111/cge.14055
  contributor:
    fullname: Damasio
– volume: 49
  start-page: 223
  year: 2017
  ident: B115
  article-title: Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia
  publication-title: Nat. Genet.
  doi: 10.1038/ng.3740
  contributor:
    fullname: Meyer
– volume: 155
  start-page: 536
  year: 1995
  ident: B15
  article-title: Interference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolase
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.155.2.536
  contributor:
    fullname: Benveniste
– volume: 31
  start-page: 899
  year: 2016
  ident: B62
  article-title: Intrathecal injections in children with spinal muscular atrophy: Nusinersen clinical trial experience
  publication-title: J. Child. Neurol.
  doi: 10.1177/0883073815627882
  contributor:
    fullname: Hache
– volume: 397
  start-page: 161
  year: 2007
  ident: B169
  article-title: Trithorax-group protein ASH1 methylates histone H3 lysine 36
  publication-title: Gene
  doi: 10.1016/j.gene.2007.04.027
  contributor:
    fullname: Tanaka
– volume: 22
  start-page: 245
  year: 2018
  ident: B56
  article-title: Review of the phenotype of early-onset generalised progressive dystonia due to mutations in KMT2B
  publication-title: Eur. J. Paediatr. Neurol.
  doi: 10.1016/j.ejpn.2017.11.009
  contributor:
    fullname: Gorman
– volume: 20
  start-page: 2223
  year: 2006
  ident: B28
  article-title: A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced
  publication-title: Genes. Dev.
  doi: 10.1101/gad.380906
  contributor:
    fullname: Chaumeil
– volume: 5
  start-page: 505
  year: 2008
  ident: B6
  article-title: Factors affecting the clearance and biodistribution of polymeric nanoparticles
  publication-title: Mol. Pharm.
  doi: 10.1021/mp800051m
  contributor:
    fullname: Alexis
– volume: 6
  start-page: e23320
  year: 2011
  ident: B179
  article-title: Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0023320
  contributor:
    fullname: Watanabe
– volume: 56
  start-page: 89
  year: 2019
  ident: B1
  article-title: Kabuki syndrome: International consensus diagnostic criteria
  publication-title: J. Med. Genet.
  doi: 10.1136/jmedgenet-2018-105625
  contributor:
    fullname: Adam
– volume: 51
  start-page: 1114
  year: 2012
  ident: B172
  article-title: Involvement of the MLL gene in adult T-lymphoblastic leukemia
  publication-title: Genes. Chromosom. Cancer
  doi: 10.1002/gcc.21996
  contributor:
    fullname: Turkmen
– volume: 23
  start-page: 1103
  year: 2002
  ident: B12
  article-title: The impact of chromatin in human cancer: Linking DNA methylation to gene silencing
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/23.7.1103
  contributor:
    fullname: Ballestar
– volume: 44
  start-page: 609
  year: 2011
  ident: B91
  article-title: NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming
  publication-title: Mol. Cell.
  doi: 10.1016/j.molcel.2011.08.042
  contributor:
    fullname: Kuo
– volume: 90
  start-page: 10489
  year: 1993
  ident: B9
  article-title: Topography of the histone octamer surface: Repeating structural motifs utilized in the docking of nucleosomal DNA
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.90.22.10489
  contributor:
    fullname: Arents
– volume: 821
  start-page: 146287
  year: 2022
  ident: B43
  article-title: Functional validation of variants of unknown significance using CRISPR gene editing and transcriptomics: A Kleefstra syndrome case study
  publication-title: Gene
  doi: 10.1016/j.gene.2022.146287
  contributor:
    fullname: Fear
– volume: 32
  start-page: 236
  year: 2022
  ident: B29
  article-title: Kleefstra syndrome with severe sensory neural deafness and de novo novel mutation
  publication-title: J. Coll. Physicians Surg. Pak
  doi: 10.29271/jcpsp.2022.02.236
  contributor:
    fullname: Cheema
– volume: 406
  start-page: 593
  year: 2000
  ident: B140
  article-title: Regulation of chromatin structure by site-specific histone H3 methyltransferases
  publication-title: Nature
  doi: 10.1038/35020506
  contributor:
    fullname: Rea
– volume: 21
  start-page: 366
  year: 2014
  ident: B11
  article-title: Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.2796
  contributor:
    fullname: Aymard
– volume: 270
  start-page: 2620
  year: 1995
  ident: B61
  article-title: Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.6.2620
  contributor:
    fullname: Guvakova
– volume: 46
  start-page: 6
  year: 2020
  ident: B149
  article-title: Invited review: Epigenetics in neurodevelopment
  publication-title: Neuropathol. Appl. Neurobiol.
  doi: 10.1111/nan.12608
  contributor:
    fullname: Salinas
– volume: 399
  start-page: 372
  year: 2022
  ident: B50
  article-title: Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: Long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)02017-1
  contributor:
    fullname: Fumagalli
– volume: 39
  start-page: 311
  year: 2007
  ident: B66
  article-title: Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
  publication-title: Nat. Genet.
  doi: 10.1038/ng1966
  contributor:
    fullname: Heintzman
– volume: 9
  start-page: e1003897
  year: 2013
  ident: B119
  article-title: Ash1l methylates Lys36 of histone H3 independently of transcriptional elongation to counteract polycomb silencing
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1003897
  contributor:
    fullname: Miyazaki
– volume: 19
  start-page: 50
  year: 2023
  ident: B84
  article-title: Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration
  publication-title: Bioact. Mater
  doi: 10.1016/j.bioactmat.2022.03.039
  contributor:
    fullname: Kim
– volume: 327
  start-page: 198
  year: 2010
  ident: B97
  article-title: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
  publication-title: Science
  doi: 10.1126/science.1178178
  contributor:
    fullname: Lanford
– volume: 11
  start-page: 726
  year: 2011
  ident: B14
  article-title: A decade of exploring the cancer epigenome - biological and translational implications
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3130
  contributor:
    fullname: Baylin
– volume: 13
  start-page: e1006864
  year: 2017
  ident: B88
  article-title: Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1006864
  contributor:
    fullname: Koemans
– volume: 26
  start-page: 2013
  year: 2021
  ident: B90
  article-title: Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome
  publication-title: Mol. Psychiatry
  doi: 10.1038/s41380-020-0725-5
  contributor:
    fullname: Kummeling
SSID ssj0001257583
Score 2.2776432
SecondaryResourceType review_article
Snippet Neurodevelopmental disorders encompass a group of debilitating diseases presenting with motor and cognitive dysfunction, with variable age of onset and disease...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1090046
SubjectTerms brain organoids
Cell and Developmental Biology
epigenetics (chromatin remodeling)
histone lysine methyltransferases (HKMTs)
neurodevelopmental disorders (NDDs)
small-activating RNA (saRNA)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS91AEF-KUOilaFvrs7ZsoTdJTbKb_fBmS0UK9VAqeFt2MxMqSBTf8-B_35nd-HxPBC89BfI5mZns_Gaz8xshvtQ-Ra9rrJqUbKUB28qbSFmrBbQdNlZpLhT-dWpOzvTP8-58pdUXrwkr9MBFcQeWEL_n1WSUpWtIFGC6RKhbOUgJGiyjb92uJFNldoVgiFOlSoayMH8w8ET4V24WzgxKnBauRaJM2P8Uyny8WHIl-hxvitcTbJRHRdwt8QLHN-JlaSR591bMM9vHiJIJRmjDfaHvLhcZlOINBaoq16wgyMxfCQ8rheimMBFwzg9lX9ia5HKmTcYR5Dz-Pj2ShX1EloItyq_fibPjH3--n1RTO4Wqpxx4QaMtoYlmQKdbrUD30SdofTLOgPPRtNrBgL43fYcUxQc_DDEq6_vaaQrjTqltsTHSq-wIOWCrbQSLYEB3XNtLYS02UKPpk4k4E_v3qg3XhTUjULbBhgjZEIENESZDzMQ31v7yTGa8zjvID8LkB-E5P5iJz_e2C_SF8EPiiFe388A1oiQeIdWZeF9suXyUMgRw246udmtWXpNl_ch48TezcPOPEd8atfs_pP8gXrFGcq283RMbi5tb_EhoZ5E-Zcf-B-c3AII
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9RAEB5qRfClWH-eWlnBN0m9JJv9IYi0YilC-yAe9G3ZzU6sUFK9XKH33zuzmzt7Ut98CiTZZDOTzXzfZucbgDdTG7yVUyzKEHQhI1aFVZ5Yq46oGyx1LTlR-ORUHc_kl7PmbAtW5Y5GAw63UjuuJzWbX-xf_1p-pAH_gRknxdt3Hc9x73MdcBZHYsZ3B-5WFBl5idfJCPfznAuBE1Pn3Jl_NN2IT0nG_zbs-fcSyhsx6egB7IxgUhxk7-_CFvYP4V4uL7l8BEPSAOlRsOwIbbha9PJikaAqzil8FSmTBaNIqpbxz_ohumgcZTmH96LNGk5iPf8mfB_F4L-eHoisSSJyGhex7scwO_r87dNxMRZZKFpixgv6BhPGKDs0kiwWZettiJUNyqhorFeVNLFD26q2QYrtne0672tt26mRFNxNXT-B7Z4e5RmIDiupfdQYVZQNZ_xSsPNlnKJqg_I4gbcr07qfWUvDEQdhR7jkCMeOcKMjJnDI1l-fyTrYacfl_Lsbh5XTxActrzWkljIGgh9NIE5WmxhCLLGawOuV7xyNG76J7_HyanCcOUrdI_w6gafZl-tb1Ypgb9VQa7Ph5Y2-bB7pf5wnbW7-XWIrVT__H71_AffZIimDXr-E7cX8CvcIAy3Cq_Ri_wbzfwkz
  priority: 102
  providerName: Scholars Portal
Title Histone lysine methyltransferase-related neurodevelopmental disorders: current knowledge and saRNA future therapies
URI https://www.ncbi.nlm.nih.gov/pubmed/36923252
https://www.proquest.com/docview/2854429193
https://pubmed.ncbi.nlm.nih.gov/PMC10009263
https://doaj.org/article/71449bf4d2024db3815b96038dbbd1e2
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBVJoNBL6Xe3TYMKvRXvri1ZH7mloSEUNpTSQG5C0ozbQOKE3c0h_74jyd5mS0-92GBbtqyRPe8NM0-MfZzb4K2cY1WHoCsJ2FRWeWKtGlC3WGshU6Hw4kydnsuvF-3FDlNjLUxO2o_hctpfXU_7y185t_L2Os7GPLHZt8VxiknbRonZLtsl__uAo5fICkEQI0qFDDEwO-tSEHyaFgpP6kmJEm55oSzW_y-E-Xei5APPc_KUPRkgIz8qXXvGdrB_zh6VRSTvX7BVVvrokSdxEdqlNaHvr9YZkOKSnFSV61UQeNauhD9ZQnRTGMQ3V4c8FqUmvomycd8DX_nvZ0e8KI_wUqxF3PolOz_58uP4tBqWUqgi8d81_WkJSdQdGtlIATJ6G6CxQRkFxnrVSAMd2qhii-TBO9t13gtt49xIcuFGiFdsr6dXecN4h43UHjSCAtmmul5yab6GOaoYlMcJ-zQOrbstihmOmEYyhMuGcMkQbjDEhH1Oo7-5Mqld5wM3y59usLnTxPpsyiiklhICgYw2EPMSBkKAGpsJ-zDaztHXkR7ie7y5W7lUH0rdI5Q6Ya-LLTePEorAbdNSa7Nl5a2-bJ-hCZkVuMcJ-Pb_m75jj9M45Op4vc_21ss7fE_4Zh0OclyAtgtpDvLU_g0RYQHF
link.rule.ids 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgQXxJvlaSRuKLub2PGDW6moFuiuEGql3iw_JlCpTavd7aH_nrGTLF3EiVOkJI4dj5P5vtHMZ4D3U-OdEVMsSu9VISJWhZGOWKuKqGosFRepUHi-kLNj8fWkPtkBOdTC5KT94E_H7dn5uD39lXMrL8_DZMgTm3yf76eYtKkkn9yC2zVXprzB0rvYCoEQzbsaGeJgZtKkMPg4bRWe9JMSKdzyQ1mu_18Y8-9UyRu-5-AB3O9BI9vrBvcQdrB9BHe6bSSvH8Mqa320yJK8CB3SrtDXZ-sMSXFJbqrIFSsYWVavjH_yhOihsZffXH1kodNqYps4G3NtZCv3Y7HHOu0R1pVrEbt-AscHn4_2Z0W_mUIRiAGv6V9LWKJsUItK8CiCMz5WxkstozZOVkLHBk2QoUby4Y1pGudoasNUC3LimvOnsNvSqzwH1mAllIsKo4yiTpW95NRcGacog5cOR_BhmFp72WlmWOIayRA2G8ImQ9jeECP4lGZ_c2fSu84nLpY_bW91q4j3mZRTSC1F9AQzak_ci-vofSyxGsG7wXaWvo_UiWvx4mplU4UoDY9w6giedbbcdMUlwduqptZ6y8pbY9m-Qksya3APS_DF_zd9C3dnR_NDe_hl8e0l3Etzkmvl1SvYXS-v8DWhnbV_k5f2b5xQA0s
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWgCMQF8VkWKBiJG8pmEzuOza20rMpHVxWiUm-WnZm0ldp0tdke-u8Z29mlizhxipTEseNxMu-NZp4Z-zAx3hk5wazwvs4kYJkZ5Yi11oB1hUUtZCgUPpypg2P57aQ6GbIq-yGtsmv8-bi7uBx352cxt3J-2eSrPLH86HAvxKRNqUQ-hza_y-5VglbZLaae4isERLRIdTLEw0zehlD4OGwXHjSUAjHc8EVRsv9fOPPvdMlb_mf6mD0agCPfTQN8wu5g95TdT1tJ3jxjfdT76JAHiRE6hJ2hby6WEZbiglxVFqtWEHhUsIQ_uUL0UBgkOPtPvEl6TXwda-OuA967n7NdnvRHeCrZIob9nB1Pv_zaO8iGDRWyhljwkv63hCeKFrUspQDZOOOhNF5pBdo4VUoNLZpGNRWSH29N2zpHU9tMtCRHroV4wbY6epWXjLdYytpBjaBAVqG6lxybK2CCqvHK4Yh9XE2tnSfdDEt8IxjCRkPYYAg7GGLEPofZX98ZNK_jiavFqR0sb2vifibkFVJLCZ6gRuWJfwkN3kOB5Yi9X9nO0jcSOnEdXl33NlSJ0vAIq47YdrLluiuhCOKWFbXWG1beGMvmFVqWUYd7tQxf_X_Td-zB0f7U_vg6-_6aPQxTEsvl6zdsa7m4xh0CPEv_Nq7s3z5vBF4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Histone+lysine+methyltransferase-related+neurodevelopmental+disorders%3A+current+knowledge+and+saRNA+future+therapies&rft.jtitle=Frontiers+in+cell+and+developmental+biology&rft.au=Charlotte+Roth&rft.au=Helena+Kilpinen&rft.au=Helena+Kilpinen&rft.au=Manju+A.+Kurian&rft.date=2023-02-27&rft.pub=Frontiers+Media+S.A&rft.eissn=2296-634X&rft.volume=11&rft_id=info:doi/10.3389%2Ffcell.2023.1090046&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_71449bf4d2024db3815b96038dbbd1e2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-634X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-634X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-634X&client=summon